The Conversation (0)
Relevium Technologies released a corporate update to shareholders on its recent acquisition of BioGanix and the closing of the final tranche of the equity financing.
Relevium Technologies (TSXV:RLV) released a corporate update to shareholders on its recent acquisition of BioGanix and the closing of the final tranche of the equity financing.
As quoted in the press release:
CEO update on the recent acquisition of BioGanix
As announced in a press release dated June 12, 2017, the Company completed the acquisition of BioGanix and it is currently operating the business under BGX E-Health LLC, a US based wholly-owned subsidiary of Relevium Technologies. In the first two weeks of operations, BGX E-Health has generated close to 200,000$ in sales revenues from its existing BioGanix brand of nutraceutical products.
Aurelio Useche, CEO of Relevium Technologies stated: “The addition of BioGanix is a stepping stone in our strategic plans to building a portfolio of e-commerce brands in the Health and Wellness space. In addition to expanding the current product offering of BioGanix through the introduction of new products, the Company plans to also launch parallel brands under BGX E-Health in order to target specific segments.”
Click here to read the full press release.
Source: www.marketwired.com